These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7849935)

  • 1. Oxidative assessment of phospholipid-stabilized perfluorocarbon-based blood substitutes.
    Tarara TE; Malinoff SH; Pelura TJ
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1287-93. PubMed ID: 7849935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of perflubron emulsions with egg yolk phospholipid.
    Pelura TJ; Johnson CS; Tarara TE; Weers JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):845-8. PubMed ID: 1391521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid.
    Putyatina TK; Aprosin UD; Afonin NI
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1281-5. PubMed ID: 7849934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of semifluorinated alkanes in blood-substitutes.
    Meinert H; Knoblich A
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rheological behavior of blood substitutes with a perfluorocarbon base].
    Draffehn J; Reichelt H
    Pharmazie; 1991 Nov; 46(11):800-2. PubMed ID: 1725823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the influence of the aqueous phase bioconstituent environment on the F-19 T1 of perfluorocarbon blood substitute emulsions.
    Thomas SR; Pratt RG; Millard RW; Samaratunga RC; Shiferaw Y; Clark LC; Hoffmann RE
    J Magn Reson Imaging; 1994; 4(4):631-5. PubMed ID: 7949694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):805-18. PubMed ID: 1391515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluorooctyl bromide dispersions in aqueous media for biomedical applications.
    Habif SS; Normand PE; Oleksiak CB; Rosano HL
    Biotechnol Prog; 1992; 8(5):454-7. PubMed ID: 1369226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of buffer pH and phosphate concentration on the droplet size and EYP hydrolysis of perflubron/EYP emulsions.
    Song D; Pelura TJ; Liu J; Ni Y
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1299-305. PubMed ID: 7849937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drop size stability assessment of fluorocarbon emulsions.
    Krafft MP; Postel M; Riess JG; Ni Y; Pelura TJ; Hanna GK; Song D
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):865-8. PubMed ID: 1391525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of formulation, processing and storage parameters on the characteristics and stability of perflubron emulsion.
    Ni Y; Pelura TJ; Sklenar TA; Kinner RA; Song D
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1307-15. PubMed ID: 7849938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen solubility, rheology and hemodynamics of perfluorocarbon emulsion blood substitutes.
    Millard RW
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):235-44. PubMed ID: 8087245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorocarbon emulsions--the stability issue.
    Postel M; Riess JG; Weers JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):991-1005. PubMed ID: 7849970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe).
    Jayaraman MS; Graham K; Unger EC
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):783-789. PubMed ID: 30873883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorocarbon-based oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stable perfluorochemical blood substitute.
    Mukherji B; Sloviter HA
    Transfusion; 1991 May; 31(4):324-6. PubMed ID: 2020995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of perfluorocarbon emulsions and their compatibility with blood serum.
    Kuznetsova IN
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Mar; 26(2):181-9. PubMed ID: 9564436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of newly developed perfluorocarbon emulsion: oxygen carrying capacity as the blood substitute in vivo.
    Sakanoue J; Tamura M; Fukushima S; Takeuchi Y; Sakuma I; Kitabatake A
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Sep; 29(5):389-97. PubMed ID: 11708662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.